Second Primary Malignancies in Patients with Pancreatic Neuroendocrine Neoplasms: A Population-Based Study on Occurrence, Risk Factors, and Prognosis
Background. This study aimed to evaluate the risk factors of developing second primary malignancies (SPMs) among patients with pancreatic neuroendocrine neoplasms (pNENs) and the prognosis of pNENs patients with SPMs (pSPMs) using data from the Surveillance, Epidemiology, and End Results (SEER) data...
Guardado en:
Autores principales: | Tulan Hu, Wei Wang, Chiyi He |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Hindawi Limited
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/cda6b2f0c7f2445a802c940992296279 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Cdk5 drives formation of heterogeneous pancreatic neuroendocrine tumors
por: Angela M. Carter, et al.
Publicado: (2021) -
Risk of second primary malignancies in patients with follicular lymphoma: a population-based study in the Netherlands, 1989-2018
por: Manette A. W. Dinnessen, et al.
Publicado: (2021) -
Malignant neoplasm of the bronchi and lung: Russian clinical guidelines
por: Konstantin K. Laktionov, et al.
Publicado: (2021) -
Case Report: Response With Immunotherapy in a Patient With Mixed Neuroendocrine Non-Neuroendocrine Neoplasms of the Gallbladder
por: Chao Liu, et al.
Publicado: (2021) -
Thrombocytosis in COVID-19 patients without myeloproliferative neoplasms is associated with better prognosis but higher rate of venous thromboembolism
por: Marko Lucijanic, et al.
Publicado: (2021)